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Objectives: The purpose of this study was to determine whether the ratio of the area
of the mediastinal computed tomographic image to that of the lung computed
tomographic image can be a prognostic factor of small peripheral lung adenocar-
cinoma.
Methods: We studied the computed tomographic images of 143 patients with
primary peripheral lung adenocarcinoma of 30 mm or less in maximum diameter.
Two groups were categorized according to the tumor’s ratio of the area of the
mediastinal computed tomographic image to that of the lung computed tomographic
image (tumor’s area in the mediastinal computed tomographic image/tumor’s area
in lung computed tomographic image 100%), both faint density-type (50%) and
solid-type images (50%). Clinical factors and prognoses of the 2 groups were
analyzed.
Results: There were 58 patients with the solid-type tumor image and 85 patients
with the faint density–type tumor image. The number of patients with tumor size of
less than 20 mm in the faint density–type tumor group (n  30) was significantly
higher than that in the solid-type tumor group (n 8, P .008). The 5-year survival
of patients with faint density–type tumors was 74.1%, whereas that in patients with
solid-type tumors was 54.2% (P .013). Furthermore, the survival curve of patients
with the solid-type computed tomographic image combined with ground-glass
opacity was similar to that of patients with the faint density–type image. Multivar-
iate analysis revealed the prognostic influence of the ratio of the area of the
mediastinal computed tomographic image to that of the lung computed tomographic
image on survival (P  .029, relative risk  0.48) and showed to be of second
highest influence after the N factor.
Conclusions: It is suggested that the ratio of the area of the mediastinal computed
tomographic image to that of the lung computed tomographic image can be a
prognostic factor in patients with small peripheral lung adenocarcinoma.
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Recently, the number of patients with smallperipheral lung cancer detected by meansof computed tomographic (CT) scanninghas been increasing. In Japan, CT massscreening has been started in many localmunicipalities. Most cancers detected by
this method are small stage IA lung cancers in peripheral
locations. In the United States the National Cancer Institute
launched lung cancer screening with spiral CT scanning.
Despite the small size of these tumors, some patients die of
cancer recurrence, and thus it is important for us to know the
biologic behavior of this type of cancer. Although many
reports on the radiologic-pathologic correlation of small
lung adenocarcinoma have been published, little clinical
information on prognostic factors during the pretreatment
state is available.1-5 Thus, new information relevant to prog-
nosis is highly desired.
Patients and Methods
From January 1990 to December 1993, surgical resections were
performed in 143 patients with primary peripheral lung adenocar-
cinoma with a maximum diameter of 30 mm or less. Of the 143
patients, 136 (95.1%) underwent lobectomies, 5 (3.5%) underwent
pneumonectomies, and 2 (1.4%) underwent segmental resections
combined with systematic hilar and mediastinal node dissection.
Informed consent was obtained from each patient before the op-
Figure 1. CT images of a patient with a solid-type tumor with GGO. The patient was a 70-year-old woman who
underwent a right upper lobectomy combined with systematic nodal dissection. She remained alive for 7.6 years
after the operation. The CT M/L ratio was 60.5%, and GGO was found around the solid-type tumor image. The tumor
was proved to be a well-differentiated stage IIA (T1 N1 M0) papillary adenocarcinoma with a maximum tumor
diameter of 25 mm.
Figure 2. CT images of a patient with a faint density–type tumor with GGO. The patient was a 72-year-old man who
underwent a right upper lobectomy combined with systematic nodal dissection. He was still alive as of the last
follow-up (9.5 years). The CT M/L ratio was 3.9%, and GGO was observed. The tumor was proved to be moderately
differentiated stage IA (T1 N0 M0) papillary adenocarcinoma with a maximum tumor diameter of 20 mm.
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eration. Tumors were completely removed in 137 patients, but 6
had residual tumors: 3 patients had malignant pleural effusion; 1
patient had pleural dissemination; 1 patient had malignant pericar-
dial effusion; and 1 patient had residual tumor at the bronchial
stump. CT images were photographed with a window level of
600 H and window width of 2000 H for lung windows and a
level of 10 H and width of 300 H for mediastinal windows. Each
image was analyzed with National Institutes of Health imaging
software. The areas in the lung and mediastinal windows of the
tumors were both measured 3 times. Mean values were used to
calculate the tumor’s ratio of the area of the mediastinal computed
tomographic image to that of the lung computed tomographic
image (CT M/L ratio; CT M/L ratio  tumor’s area in the medi-
astinal CT image/tumor’s area in the lung CT image  100%). All
patients were classified into one of two groups: the solid-type
tumor group (CT M/L ratio 50%) and the faint density–type
tumor group (CT M/L ratio 50%).6 Examples of CT images of
the two groups are shown in Figures 1 and 2. Tumors with
ground-glass opacity (GGO)7 in lung CT images were defined as
GGO positive. The medical records of all patients were reviewed
for clinical and pathologic characteristics, including age, sex,
tumor size, lymph node involvement, pathologic stage, and histo-
logic grade. The length of survival was defined as the period from
the day of the operation to the last day of follow-up or the date of
death from any cause. The survivals were calculated by means of
the Kaplan-Meier method, and statistical analysis was performed
by means of the log-rank test. The 2 test or Fisher exact test was
used to compare several clinical or pathologic factors. The Cox
proportional hazards model was applied for multivariate analysis
by using version 5.0 of the StatView software package (SAS
Institute Inc, Cary, NC).
Results
Patient characteristics are summarized in Table 1. There
were 58 patients with solid-type tumors and 85 patients with
faint density–type tumors. There was no significant differ-
ence in age distribution and sex between the two groups. Of
58 patients with solid-type tumors, only 8 had tumors with
maximum diameters of 20 mm or less, whereas there were
30 patients in the total of 85 with faint density–type tumors
(P  .008). Thirty-seven patients with solid-type tumors
proved to have no nodal involvement, 2 patients had N1
disease, and 19 had N2 disease pathologically. In the faint
density group the numbers of patients with no nodal in-
volvement, N1 disease, and N2 disease were 68, 6, and 11,
respectively. The number of patients with nodal involve-
ment was significantly higher in the solid-type tumor group
than that among the patients with faint density–type tumors
(P .032). We also compared histologic grade between the
two groups but found no statistical difference (P .056). In
the lung CT images of patients with faint density–type
tumors, 45 were proved to have GGO, and 40 were proved
not to have GGO. In the solid-type tumor group, on the
Figure 3. Survival curves of patients with completely resected tumors. The survival of patients with faint
density–type CT images was significantly higher than that of patients with solid-type CT images (P .013, log-rank
test).
General Thoracic Surgery Dong et al
1016 The Journal of Thoracic and Cardiovascular Surgery ● November 2002
G
TS
other hand, only 7 patients had GGO, and 41 did not (P 
.0001).
The 5-year survival of patients with faint density–type
images whose tumors were completely resected was 74.1%,
which was significantly higher than that of patients with
solid-type CT images (5-year survival, 54.2%; P  .013;
Figure 3). To exclude the influence of lymph node metas-
tasis, we also compared the survivals of the patients with
stage IA disease between the two groups. The 5-year sur-
vival of patients with stage IA disease with faint density–
type images was 86.1%, whereas it was 74.5% in the other
group, which showed a significant difference (P  .047,
Figure 4). The curve of patients with solid-type images
without GGO showed the worst survival. However, there
was no significant difference among patients with faint
density–type tumors with GGO, faint density–type tumors
without GGO, and solid-type tumors with GGO (Figure 5).
A significant difference existed between the prognosis of
the solid-type tumor group without GGO and that of the
group consisting of faint density–type and solid-type tumors
with GGO (P  .005, Figure 6).
The multivariate analysis (Table 2) showed the CT M/L
ratio to be a significant prognostic factor (P  .03; hazard
ratio, 0.48; 95% confidence interval, 0.24-0.95). The P
value of the CT M/L ratio was the second highest after that
of the N factor and was the same as that of tumor size.
Discussion
Several factors, such as lymph node metastasis, histologic
subtype (as proposed by Noguchi and colleagues8), and size
of central fibrosis, have been proved to be of prognostic
importance, but few of them can be evaluated preoperative-
ly.1-5,9 In this study we found that the 5-year survivals of
patients with faint density–type CT images were signifi-
cantly better than those of patients with solid-type CT
images (Figure 3). There was also a significant difference
between the two groups, even if the cases were limited to
stage IA disease (Figure 4). Furthermore, patients with
solid-type CT images who had no GGO component had the
worst 5-year survival (Figures 5 and 6). The multivariate
analysis revealed the prognostic influence of the CT M/L
ratio on survival (P  .029; relative risk, 0.48; Table 2),
with its effect being the second highest after that of the N
factor. All these findings strongly suggest that the CT M/L
ratio might be a possible prognostic factor of peripheral
lung adenocarcinomas 30 mm or less in size that can be
evaluated preoperatively.
The reason why patients with small peripheral lung ad-
enocarcinomas with solid-type CT images have a poor
prognosis is still unclear. Isobe and coworkers10 reported
that small peripheral lung lesions that have high CT M/L
ratios (the solid type) often appear as poorly differentiated
adenocarcinomas. On the other hand, tumors with 0% CT
M/L ratios often appear as well-differentiated adenocarci-
nomas. Andoh and associates6 studied the roentgenopatho-
logic correlation of 12 patients with small peripheral ade-
nocarcinomas measuring 15 mm or less in greatest
dimension and found that all patients (n  4) who had a
faint density type of thin-section CT images were classified
as having histologic subtypes A and B (Noguchi classifica-
tion).8 Among the 8 patients of the solid-type tumor group,
there were also 3 patients classified as having subtypes A
and B in whom the alveolar spaces were filled with mucus.
Therefore, it cannot be demonstrated that the change of the
tumor’s area in the thin-section CT image correlates with
the histologic subtype of Noguchi’s classification. However,
our study demonstrated that CT image comparison between
the mediastinal and lung CT images is possibly of prognos-
tic value in patients with peripheral lung adenocarcinoma.
Because our study included patients whose tumors were
larger than 15 mm, the biologic behavior and clinical values
of the CT images are different from those in the previous
studies, which dealt with only small nodules.
It is generally thought that most adenocarcinomas de-
velop either de novo or through the stage of atypical adeno-
TABLE 1. Characteristics and CT images of patients with
adenocarcinoma of the lung (tumor diameter <30 mm, n 
143)
No. of
patients
CT findings
Solid
type* Faint density type†
Total 143 58 85
Sex
Male 65 28 37
Female 78 30 48
Age (y) 62.6 9.9 62.5 9.9 62.8 9.9
Tumor size
20 mm 38 8 30
20 mm 105 50 55
Nodal involvement
N0 105 37 68
N1 8 2 6
N2 30 19 11
p Stage
Stage I 101 35 66
Stage II 8 2 6
Stage III 33 20 13
Stage IV 1 1 0
Histologic grade
Well 52 18 34
Moderate 73 36 37
Poor 18 4 14
GGO
 52 7 45
 91 51 40
*Solid type: tumor’s area in mediastinal window/tumor’s are in lung win-
dow 50%.
†Faint density type: tumor’s area in mediastinal window/tumor’s area in
lung window 50%.
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matous hyperplasia.11 Several investigators have reported
that GGO demonstrated by means of high-resolution com-
puted tomography might be due to bronchioloalveolar ade-
noma of the lung or bronchioloalveolar carcinoma.7,12,13 In
the study by Jang and associates,14 follow-up CT scans in 3
of 4 patients with bronchioloalveolar carcinoma showed
replacement of the GGO by means of consolidation, leading
to speculation that the areas of GGO might represent an
early stage of bronchioloalveolar carcinoma. Kodama and
coworkers15 proved that the bronchioloalveolar carcinoma
area was well correlated with the GGO area on high-reso-
lution computed tomography. He also showed that the
3-year relapse-free survivals of patients with GGO of
greater than 50% were significantly better than those of
patients with GGO of less than 50%. All of these findings
suggest that GGO is well correlated with the development
and malignant progression of some adenocarcinomas of the
lung. It was also supported by our finding that tumors of the
solid-type CT image group without GGO had the worst
prognosis (Figures 5 and 6).
In conclusion, our results suggest that the CT M/L ratio
is a possible prognostic factor of small peripheral lung
adenocarcinoma of 30 mm or less, which can be evaluated
preoperatively. The multivariate analysis showed the prog-
nostic influence of the CT M/L ratio on survival to be the
second highest after that of the N factor. We believe that
Figure 4. Survival curves of patients with stage IA disease. The survival of patients with faint density–type CT
images was significantly higher than that of patients with solid-type CT images (P  .047, log-rank test).
TABLE 2. Multivariate analyses of prognostic factors
Variables
Estimated
coefficient SE P value
Relative risk
(95% CI)
Nodal involvement (N0 vs N12) 2.27 0.35 .0001 0.10 (0.05-0.20)
CT M/L ratio* (50% vs 50%) 0.73 0.34 .03 0.48 (0.24-0.95)
Tumor size (20 mm vs 20 mm) 0.64 0.39 .03 0.43 (0.20-0.93)
Sex (male vs female) 0.55 0.35 .12 0.58 (0.29-1.16)
Histologic grade (well vs moderate  poor) 0.44 0.43 .30 0.64 (0.28-1.49)
Age (60 y vs 60y) 0.04 0.34 .91 0.96 (0.49-1.89)
CI, Confidence interval.
*CT M/L ratio: tumor’s area in the mediastinal CT image/tumor’s area in the lung CT image  100%.
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Figure 5. Survival curves on the basis of CT images (with or without GGO in both types). There were no significant
differences among patients with faint density–type tumors with GGO, solid-type tumors with GGO, and faint
density–type tumors without GGO (P 1  .89, P 2  .99, P 3  .88).
Figure 6. Survival curves of patients with solid-type tumors without GGO and of patients with other types of CT
images. There was a significant difference between the two groups (solid-type tumors without GGO vs faint
density–type tumors and solid-type tumors with GGO: P  .005).
Dong et al General Thoracic Surgery
The Journal of Thoracic and Cardiovascular Surgery ● Volume 124, Number 5 1019
G
TS
these findings hold promise for a new prognostic factor in
the pretreatment period.
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